All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
about
HIV and hepatitis C virus infection in the United States: whom and how to testHIV infection and cardiovascular diseaseHIV and aging: emerging research issuesDeterminants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, ChinaCause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyFifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012)Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaborationObesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey[The Competence Network for HIV/AIDS. Data, Samples, Facts].HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Testing a Computerized Cognitive Training Protocol in Adults Aging With HIV-Associated Neurocognitive Disorders: Randomized Controlled Trial Rationale and Protocol.Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.Inflammation, Immune Activation, and Antiretroviral Therapy in HIVResidual immune dysregulation syndrome in treated HIV infection.Are HIV-infected men vulnerable to prostate cancer treatment disparities?Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort studyChanging mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era.Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy.Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.HIV treatment outcomes among people who inject drugs in Victoria, Australia.Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.Measuring turnover of SIV DNA in resting CD4+ T cells using pyrosequencing: implications for the timing of HIV eradication therapiesCritical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort.High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugsCancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort studyEPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEAPrevalence and characteristics associated with malnutrition at hospitalization among patients with acquired immunodeficiency syndrome in Brazil.Patterns of HIV service use and HIV viral suppression among patients treated in an academic infectious diseases clinic in North Carolina.Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian settingInsurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies.
P2860
Q26996736-90407748-2D6B-4766-A66A-D5CDD89094B6Q27008915-12665826-FAFA-4361-B0CE-7C631C2ECD6AQ27016011-E1FF73B5-771D-4A6B-9860-5D942A785989Q28537961-78BC7C63-E853-4B3C-9CA7-2CF41B733106Q28553516-6A9E28F1-CE38-4CD9-B2A6-241BA1706AE3Q28553878-6B51142B-8916-4C20-A6B9-242E760A0FFDQ30583563-0392868F-E30B-40D9-BBFE-8E38637BEB80Q30979829-AE9775B5-F5E7-45FB-B7F5-E4F3BED5AE16Q31056307-72071B50-F427-4853-921D-45D7E57C282FQ33618542-CBEA7472-A768-4986-8954-B68632E5C7DFQ33649221-00996457-2CFA-4BDF-BFCB-BE4627FC46D0Q33781469-54215107-9919-42FA-8AF2-CDBB42E577E3Q33912595-6599A464-4C21-4E49-8E9B-673DAB780800Q34020121-B332ECC6-01B9-4D9B-ADCB-79079A6A016AQ34288005-8F5B2367-09AA-4DDC-815A-7576D37BEEB8Q34315572-9421DA52-D665-4812-A287-99CD43A82CF8Q34405742-93890C92-CD24-4CC5-99AD-B8B68ACD07F6Q34455423-540CC4AA-CD71-4F2C-94F5-20952217EF39Q34517842-421DCADB-778D-4099-A042-5BF02D8FECD9Q34663606-0FBEC8A1-BE37-42A5-8176-10138A9950E4Q34668617-4B09820D-ADBA-4F10-B04D-4AB7A0B14B04Q34804309-CFED761E-6F7D-41C7-B291-697FD1123D1AQ34823231-3076D818-3B30-41B5-AF4F-043D1BB47FC6Q34902580-1F07413B-C212-4D74-ACD6-CE8AC5535EBBQ34958573-B30A6452-E6D3-4523-AA6C-239347AF89FDQ34984426-F63D5AF1-8D8E-40B4-8A16-638787C1A7C2Q35071910-E964372E-D4A3-4736-BE55-8EBD3F87807CQ35072103-1D8EB60C-B881-4AF0-9064-80EB80B4422AQ35085621-74D167A1-0592-455F-8018-3ED5F9700568Q35141776-4B4B47A9-97E7-4B3F-9815-5C0607B692CDQ35146521-50B78B0B-DA1A-4945-93CF-04740BD6CDA9Q35186458-4AC30AD5-74A1-43B6-964F-F7ADE51794F3Q35189562-91375BFD-FEA1-491A-9E99-2AEB1D084F89Q35921909-54F87B03-6271-403F-B25F-5DF0E397362EQ36292161-515CC8E3-243F-44BD-ADA8-439CFA5B1399Q36364303-28ABC70A-1E6B-4C73-A85A-5B2D4056416CQ36381037-2AE0B226-FCB2-4DC1-A9CE-7A0432B2F189Q36395144-0637A487-2EDB-4BDE-8B16-AB385F3A1792Q36814748-F77E0567-ACA5-46EB-B6B3-A19971F0ED1EQ36919443-E3D473D8-2FB9-433B-B3B8-12BA7D2C2E0F
P2860
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
All-cause mortality in treated ...... vational cohort collaboration.
@en
All-cause mortality in treated ...... vational cohort collaboration.
@nl
type
label
All-cause mortality in treated ...... vational cohort collaboration.
@en
All-cause mortality in treated ...... vational cohort collaboration.
@nl
prefLabel
All-cause mortality in treated ...... vational cohort collaboration.
@en
All-cause mortality in treated ...... vational cohort collaboration.
@nl
P2093
P2860
P50
P356
P1476
All-cause mortality in treated ...... vational cohort collaboration.
@en
P2093
Carlo Torti
Catherine Leport
Charlotte Lewden
Christoph Stephan
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Cristina Mussini
George Panos
Jade Ghosn
Jan Christian Wasmuth
Jesper Grarup
P2860
P304
P356
10.1093/IJE/DYR164
P50
P577
2011-11-28T00:00:00Z